Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-16

Clinical Trial Update: Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metolazone to chlorothiazide for acute decompensated heart failure with diuretic resistance; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorothiazide (chlorothiazide)
  • METOLAZONE (metolazone)

Snippet

Sponsor: University of Virginia | Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: TERMINATED